Mediantechnologies Stock
€3.52
Your prediction
Financial data and news for Median Tech
sharewise wants to provide you with the best news and tools for Median Tech, so we directly link to the best financial data sources.
Financials
News
Median Technologies Reports Record iCRO Backlog, eyonis™ LCS On-Track for Standalone Pivotal Study Readout in August
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “the Company”) reports today its business indicators for the first half of 2024, provide an update on
Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of May 31st, 2024
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
18,418,233
Number of real voting rights* (excluding treasury shares**)
18,373,987
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 19, 2024
Regulatory News:
The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”) are invited to participate in the Shareholders’ Ordinary and
Median Technologies to Participate in the 2024 ASCO Annual Meeting, May 31 - June 4, 2024, McCormick Place, Chicago, IL, USA
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”) announced today that the Company will be participating in the 2024 American Society
Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”) (Paris:ALMDT) announced today that the Company has been selected as preferred
Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”) today reported its 2023 consolidated annual financial results, as of December 31
Median Technologies to Participate in the TD Cowen’s 44th Annual Health Care Conference
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) (Paris:ALMDT), will be participating in the TD Cowen’s 44th Annual Health Care Conference, taking place on March 4 –
Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces today that the Company will be participating and speaking at the premier European radiology conference, the
Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces its 2023 revenue, outlining both its strategic outlook and key milestones for 2024.
Fredrik Brag, Chief
New Date for Median Technologies’ Webcasts: February 1st, 2024
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on February